-transparent.png){kind=logo}
A monoclonal antibody, 5D7, was obtained after immunization of syngeneic mice with B16 melanoma cell extracts enriched for endogenous lectin activity and screening for inhibition of lectin-mediated hemagglutination. Binding of this antibody to affinity-purified B16 melanoma galactoside-specific lectin was revealed by solid-phase radioimmunoassay and binding to the surface of viable B16 cells was demonstrated by indirect immunofluorescence. Inhibition of lectin activity and cell surface labeling by 5D7 antibody were also found with several types of cultured human and murine cells including melanoma, sarcoma and carcinoma. This monoclonal antibody should be useful for evaluating the role of tumor cell surface lectins in intercellular interactions and metastasis.
A Raz, and
L Meromsky, and
P Carmi, and
R Karakash, and
D Lotan, and
R Lotan
September 1985,
Cancer research,
A Raz, and
L Meromsky, and
P Carmi, and
R Karakash, and
D Lotan, and
R Lotan
January 1985,
European urology,
A Raz, and
L Meromsky, and
P Carmi, and
R Karakash, and
D Lotan, and
R Lotan
January 2015,
Current protein & peptide science,
A Raz, and
L Meromsky, and
P Carmi, and
R Karakash, and
D Lotan, and
R Lotan
May 1988,
Journal of cellular biochemistry,
A Raz, and
L Meromsky, and
P Carmi, and
R Karakash, and
D Lotan, and
R Lotan
October 2014,
Seminars in oncology,
A Raz, and
L Meromsky, and
P Carmi, and
R Karakash, and
D Lotan, and
R Lotan
January 1986,
Anticancer research,
A Raz, and
L Meromsky, and
P Carmi, and
R Karakash, and
D Lotan, and
R Lotan
September 1985,
Proceedings of the National Academy of Sciences of the United States of America,
A Raz, and
L Meromsky, and
P Carmi, and
R Karakash, and
D Lotan, and
R Lotan
March 2007,
Expert opinion on biological therapy,
A Raz, and
L Meromsky, and
P Carmi, and
R Karakash, and
D Lotan, and
R Lotan
January 1980,
Contemporary topics in immunobiology,
A Raz, and
L Meromsky, and
P Carmi, and
R Karakash, and
D Lotan, and
R Lotan
September 1989,
International journal of cancer,
